Drug treatment of claudication: Vasodilators, hemorrheologic agents, and antiserotonin drugs
- 1 February 1986
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 3 (2) , 374-381
- https://doi.org/10.1016/0741-5214(86)90027-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Double-Blind, Crossover Study of the Clinical Efficacy and the Hemorheological Effects of Pentoxifylline in Patients With Occlusive Arterial Disease of the Lower LimbsAngiology, 1984
- Trental® 400 in the Treatment of Intermittent Claudication: Results of Long-Term, Placebo-Controlled AdministrationAngiology, 1984
- ASSESSMENT OF PHARMACOLOGICAL AGENTS WITH A HEMORHEOLOGICAL ACTIONAnnals of the New York Academy of Sciences, 1983
- Placebo Controlled Double Blind Study with Pentoxifylline of Walking Performance in Patients with Intermittent ClaudicationAngiology, 1983
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982
- Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: Results of double-blind study versus vasodilator-nylidrinAmerican Heart Journal, 1982
- Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.BMJ, 1982
- Vasodilator Drugs in Peripheral Vascular DiseaseNew England Journal of Medicine, 1979
- Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial diseaseCurrent Medical Research and Opinion, 1979
- Improvement of the Flow Properties of Blood: a New Therapeutical Approach in Occlusive Arterial DiseaseAngiology, 1976